Comparison of percutaneous coronary intervention of saphenous venous graft versus native artery in acute myocardial infarction

Aim: Percutaneus coronary intervention (PCI) is recommended as the first choice in saphenous vein graft (SVG) occlusions because of the high mortality linked with repeated coronary artery by-pass grafting (CABG). We observed percutaneous interventions performed in patients presenting with acute myocardial infarction (AMI) with a CABG history in terms of both short- and long-term efficacy and safety. Materials and Methods: The study was conducted retrospectively at a single center. In total, 95 patients with a CABG history who were admitted to our hospital with an AMI and received PCI were included in the study. Results: In-hospital deaths occurred in 4 (4.2%) patients, 30-day major adverse cardiac event (MACE) were present in 8 (8.4%) patients, and 6 (6.3%) patients experienced firstyear target vessel revascularization (TVR). A significant difference was not observed in in-hospital death, 30-days MACE, 1-year TVR and 1-year MACE rates among the patient groups who had PCI in the graft vessel or native vessel. Conclusion: Our study revealed that a significant difference was not present in terms of MACE in the intervention of SVGs or native coronary arteries. Diabetes mellitus (DM) should be kept in mind as a predictive factor.

PDF

___

1. Farag M, Gue YX, Brilakis ES, Egred M. Meta-analysis Comparing Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Grafting. Am J Cardiol. 2021 Feb 1;140:47-54. doi: 10.1016/j.amjcard.2020.10.062. Epub 2020 Nov 2.PMID: 33144169
2. J Tatoulis, BF Buxton, JA Fuller. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004;77:93- 101
3. ES Brilakis, M Lee, J Mehilli, K Marmagkiolis, J Rodes-Cabau, R Sachdeva, A Kotsia, G Christopoulos, BV Rangan, A Mohammed, S Banerjee. Saphenous vein graft interventions. Curr Treat Options Cardiovasc Med 2014;16:301
4. S Bhogal, HB Panchal, J Bagai, S Banerjee, ES Brilakis, D Mukherjee, G Kumar, M Shanmugasundaram, TK Paul. Drug- Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials. Cardiovasc Revasc Med 2019;20:758-767
5. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition after Bare-Metal Stent Implantation. Circulation. 2004 Feb 24;109(7):881–6.
6. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term followup. Circulation. 2006 Jan;113(3):414–9.
7. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998 Feb;31(2):241-51. doi: 10.1016/s0735- 1097(97)00506-8.
8. Miró Ò, Martínez-Nadal G, Koechlin L, Coll-Vinent B, Gil V, Aguiló S, Galicia M, García-Martínez A, Ortega M, Strebel I, Ayala PL, Gualandro DM, Boeddinghaus J, Nestelberger T, Bragulat E, Sánchez M, Müller C, López-Barbeito B. Influence of previous coronary artery bypass grafting in the difficulty of acute coronary syndrome diagnosis. Eur J Emerg Med. 2021 Apr 1;28(2):125-135. doi: 10.1097/MEJ.0000000000000755.
9. Deharo P, Strange JW, Mozid A. Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion. Catheter Cardiovasc Interv. 2017 Aug 1;90(2):251-256. doi: 10.1002/ccd.26905. Epub 2017 Feb 10.
10. Xenogiannis I, Nikolakopoulos I, Vemmou E, Brilakis ES. Chronic total occlusion recanalization for myocardial infarction. Catheter Cardiovasc Interv. 2020 May 1;95(6):1133-1135. doi: 10.1002/ccd.28590. Epub 2019 Nov 6.
11. Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, Damluji AA, Batchelor WB. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. JACC Heart Fail. 2020 Nov;8(11):879-891. doi: 10.1016/j.jchf.2020.09.005.
12. Zeymer U, Bueno H, Granger CB, Hochman J, Huber K, Lettino M, Price S, Schiele F, Tubaro M, Vranckx P, Zahger D, Thiele H. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(2):183-197. doi: 10.1177/2048872619894254. Epub 2020 Mar 2.
13. J Iqbal, CS Kwok, E Kontopantelis, MA de Belder, PF Ludman, M Giannoudi, M Gunning, A Zaman, MA Mamas; British Cardiovascular Intervention Society (BCIS) and the National Institute for Cardiovascular Outcomes Research (NICOR). Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery. Circ Cardiovasc Interv 2016;9:e003151
14. I Xenogiannis, P Tajti, MN Burke, ES Brilakis. Staged revascularization in patients with acute coronary syndromes due to saphenous vein graft failure and chronic total occlusion of the native vessel: A novel concept. Catheter Cardiovasc Interv 2019;93:440-444.
15. Mehta RH, Honeycutt E, Shaw LK, Glower D, Harrington RA, Sketch MH Jr. Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts. Am Heart J 2006; 152: 801-806.
16. Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR Jr, O’Neill WW, et al. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. JACC Cardiovasc Interv 2010; 3: 343-351.
17. LIU, Wei; LIU, Yu-yang; Mukku, Venkata K.; SHI, Dongmei; Lü, Shu-zheng; ZHOU, Yu-jie Long-term outcome of native artery versus bypass graft intervention in prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction Chinese Medical Journal: June 20, 2013- Volume 126- Issue 12 – p 2281-2285 doi: 10.3760/cma.j.issn.0366- 6999.20130198.
18. Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1.
19. Valina C, Neumann FJ, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, Aytekin A, Richardt G, Witzenbichler B, Sibbing D, Cassese S, Angiolillo DJ, Kufner S, Liebetrau C, Hamm CW, Xhepa E, Hapfelmeier A, Sager HB, Wustrow I, Joner M, Trenk D, Laugwitz KL, Schunkert H, Schüpke S, Kastrati A. Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2020 Nov 24;76(21):2436-2446. doi: 10.1016/j.jacc.2020.09.584.
20. Ndrepepa G, Kastrati A, Menichelli M, Neumann FJ, Wöhrle J, Bernlochner I, Richardt G, Witzenbichler B, Sibbing D, Gewalt S, Angiolillo DJ, Hamm CW, Hapfelmeier A, Trenk D, Laugwitz KL, Schunkert H, Schüpke S, Mayer K. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus. JACC Cardiovasc Interv. 2020 Oct 12;13(19):2238-2247. doi: 10.1016/j.jcin.2020.07.032.